Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 5/20 | 0.49 |
| ▸ | NPC1 | O15118 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6003417 | 0.89 | — | — | |
| SCHEMBL14506717 | 0.83 | EPHX1 (0.53) | EPHX1RAB9ANPC1SMN1; SMN2GAA | |
| SCHEMBL14492252 | 0.83 | EPHX1 (0.53) | EPHX1RAB9ANPC1SMN1; SMN2GAA | |
| SCHEMBL791883 | 0.82 | ALDH1A1 (0.67) | EPHX1RAB9ANPC1SMN1; SMN2GAA | |
| SCHEMBL15906214 | 0.82 | SMYD3 (0.54) | EPHX1RAB9ANPC1SMN1; SMN2GAA | |
| SCHEMBL13649892 | 0.82 | SMYD3 (0.54) | EPHX1RAB9ANPC1SMN1; SMN2GAA | |
| SCHEMBL6002698 | 0.81 | SMN1; SMN2 (0.65) | EPHX1RAB9ANPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL11212248 | 0.80 | KMT2A (0.58) | EPHX1SMN1; SMN2ALDH1A1HPGDLMNA | |
| SCHEMBL12385841 | 0.79 | RAB9A (0.51) | EPHX1RAB9ANPC1SMN1; SMN2GAA | |
| SCHEMBL21131668 | 0.79 | RAB9A (0.46) | EPHX1RAB9ANPC1SMN1; SMN2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791257-B2 | Substituted pyrrolotriazines as protein kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-07-29 | — | — | US | disclosed |